Sign In
Buy HQY
$85.21
-3.13 (-3.54%)
At Close: Jun 03, 2026
Bet on 5 Top-Ranked Stocks With Rising P/E for Stellar Gains
07:05am, Wednesday, 18'th Sep 2024
Tap five stocks with increasing P/E ratios. These stocks include TAL Education Group (TAL), The RealReal (REAL), DarioHealth (DRIO), HealthEquity (HQY) and Energous (WATT).
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term
10:50am, Wednesday, 11'th Sep 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2 Recession-Resistant Stocks for Tough Market Conditions
08:36am, Wednesday, 11'th Sep 2024
The fear of an economic recession has been ever prevalent for years. Investors constantly wonder how to protect their portfolios in the event of a recession.
HQY vs. MEDP: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 10'th Sep 2024
Investors interested in stocks from the Medical Services sector have probably already heard of HealthEquity (HQY) and Medpace (MEDP). But which of these two companies is the best option for those look
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
01:47pm, Monday, 09'th Sep 2024
HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.
Wall Street Analysts Believe HealthEquity (HQY) Could Rally 36.59%: Here's is How to Trade
10:56am, Monday, 09'th Sep 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 36.6% in HealthEquity (HQY). While the effectiveness of this highly sought-after metric is questionable, the po
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
10:50am, Monday, 09'th Sep 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
HealthEquity Stock May Gain From Its Latest Partnership With Paytient
02:00pm, Thursday, 05'th Sep 2024
HQY collaborates with Paytient to enhance employees' access to healthcare through Health Payment Accounts.
HealthEquity Stock Rises on Q2 Earnings and Revenue Beat
12:35pm, Wednesday, 04'th Sep 2024
HQY surpasses second-quarter expectations on robust HSA growth and improved margins. It also raises FY25 guidance.
HealthEquity, Inc. (HQY) Q2 2025 Earnings Call Transcript
08:09pm, Tuesday, 03'rd Sep 2024
HealthEquity, Inc. (NASDAQ:HQY ) Q2 2025 Earnings Conference Call September 3, 2024 4:30 PM ET Company Participants Richard Putnam - IR Jon Kessler - President & CEO James Lucania - EVP & CFO Steve Ne
HealthEquity (HQY) Reports Q2 Earnings: What Key Metrics Have to Say
07:01pm, Tuesday, 03'rd Sep 2024
While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended July 2024, it could be worth looking at how some of its key metrics compar
HealthEquity (HQY) Surpasses Q2 Earnings and Revenue Estimates
06:15pm, Tuesday, 03'rd Sep 2024
HealthEquity (HQY) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $0.53 per share a year ago.
HealthEquity Reports Second Quarter Ended July 31, 2024 Financial Results
04:01pm, Tuesday, 03'rd Sep 2024
Highlights of the second quarter include: Revenue of $299.9 million, an increase of 23% compared to $243.5 million in Q2 FY24. Net income of $35.8 million, compared to $10.6 million in Q2 FY24, wi
What Analyst Projections for Key Metrics Reveal About HealthEquity (HQY) Q2 Earnings
10:15am, Wednesday, 28'th Aug 2024
Evaluate the expected performance of HealthEquity (HQY) for the quarter ended July 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics
HealthEquity: A Checkup As We Head Into Earnings
09:11am, Wednesday, 28'th Aug 2024
HealthEquity, a provider of HSAs and CDBs, has shown strong growth and improved cash flows, leading me to upgrade it to a 'buy' in May. Despite a 2.9% drop in shares versus a 6.5% rise in the S&P 500,
